Many pandemic-driven changes to cancer clinical trials should remainJuly 28, 2021Patient & Survivor CareCOVID-19 Updates
Lack of after care leaves cancer patients in ‘survivorship abyss’July 22, 2021Patient & Survivor Care
Pediatric cancer survivors at risk for opioid misuseMay 5, 2021ALLPatient & Survivor CareOpioid Resource CenterPediatricsAMLB Cell LymphomaCLL
Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Patient & Survivor CareMultiple Myeloma
Steroid-refractory pneumonitis from ICIs: Experience at major centersApril 9, 2021Patient & Survivor CareMixed Topics
Palliative care helpful but underutilized for blood cancer patientsApril 8, 2021Patient & Survivor Care
Cancer screening stopped by pandemic: Repercussions to come?April 8, 2021Patient & Survivor CareCOVID-19 UpdatesMixed TopicsMultiple Myeloma
New guidelines on antibiotic prescribing focus on shorter coursesApril 6, 2021Patient & Survivor CareMixed Topics
Starting April 5, patients can read your notes: 5 things to considerApril 1, 2021Patient & Survivor CareMixed Topics
Paving the way for diversity in clinical trialsMarch 25, 2021Diversity in MedicinePatient & Survivor Care
FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Patient & Survivor CareMultiple Myeloma
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
JAMA editor resigns over controversial podcastMarch 11, 2021Diversity in MedicinePatient & Survivor CareMixed Topics
